<main class="detailed-guide" lang="en" role="main">
      


<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-l">
    Supplying authorised medicines to Northern Ireland
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
      
  <p class="gem-c-lead-paragraph">What you need to do to supply authorised medicines from Great Britain to Northern Ireland.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">31 December 2020</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        22 December 2021
          — <a data-track-category="content-history" data-track-label="history" data-track-action="see-all-updates-link-clicked" class="gem-c-metadata__definition-link govuk-!-display-none-print" href="#history">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>







<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    


      <div class="app-c-contents-list-with-body" data-module="sticky-element-container">
      <div class="responsive-bottom-margin">
          <nav role="navigation" aria-label="Contents" data-module="gem-track-click" class="gem-c-contents-list">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a data-track-label="#supply-of-authorised-medicines-to-northern-ireland" class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-options="{&quot;dimension29&quot;:&quot;1. Supply of authorised medicines to Northern Ireland&quot;}" href="#supply-of-authorised-medicines-to-northern-ireland" data-track-category="contentsClicked" data-track-action="content_item 1">1. Supply of authorised medicines to Northern Ireland</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a href="#licensing-requirements-for-medicines-containing-controlled-drugs" data-track-category="contentsClicked" data-track-action="content_item 2" data-track-label="#licensing-requirements-for-medicines-containing-controlled-drugs" class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-options="{&quot;dimension29&quot;:&quot;Licensing requirements for medicines containing controlled drugs&quot;}">Licensing requirements for medicines containing controlled drugs</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a href="#contact" class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-options="{&quot;dimension29&quot;:&quot;Contact&quot;}" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#contact">Contact</a>

        </li>
    </ol>
</nav>
      </div>
    
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>

        
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
          <div class="govspeak">
<h2>1. Supply of authorised medicines to Northern Ireland</h2>

<p>Medicines for the Northern Ireland market must follow the <abbr title="European Union">EU</abbr> acquis as per the Northern Ireland Protocol with a pragmatic approach to applying <abbr title="European Union">EU</abbr> rules on importation and unique identifier requirements. This is as set out in the <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/943233/Draft_unilateral_declarations_by_the_European_Union_and_the_United_Kingdom_of_Great_Britain_and_Northern_Ireland_in_the_Withdrawal_Agreement_Joint_Committee_on_human_and_veterinary_medicines.pdf" class="govuk-link" rel="external">draft <abbr title="European Union">EU</abbr> Unilateral Declaration in the Withdrawal Agreement Joint Committee</a>.</p>

<p>Batch testing and <abbr title="Qualified Person">QP</abbr> certification will continue to be required to place a product on the UK market as per the requirements detailed in <a rel="external" class="govuk-link" href="https://www.legislation.gov.uk/uksi/2012/1916/regulation/41/made">regulation 41(2) of the Human Medicines Regulations 2012</a>.</p>

<p>Batch testing and <abbr title="Qualified Person">QP</abbr> certification done in Great Britain (England, Wales and Scotland) will enable supply of medicines with a valid marketing authorisation to Northern Ireland. Batch testing and <abbr title="Qualified Person">QP</abbr> certification done in the <abbr title="European Union">EU</abbr>/<abbr title="European Economic Area">EEA</abbr> will also enable supply to Northern Ireland via Great Britain (including packs not moved under transit procedures using the Common Transit Convention).</p>

<p>Medicines can be supplied from the Great Britain market to Northern Ireland without requiring additional regulatory importation controls (manufacture and import authorisation, batch testing and <abbr title="Qualified Person">QP</abbr> certification done in Northern Ireland or an <abbr title="European Economic Area">EEA</abbr> state). This means that wholesale dealers can continue to supply medicines from Great Britain to Northern Ireland.</p>

<p>There are alternative supply chain options for Northern Ireland. These include:</p>

<ul>
  <li>Use of the Common Transit Convention when transporting goods via Great Britain</li>
  <li>Routing Northern Ireland logistics directly from the <abbr title="European Economic Area">EEA</abbr>
</li>
</ul>

<p>The serialisation requirements of <abbr title="European Union">EU</abbr> Delegated Regulation 2016/161 will continue in Northern Ireland. Medicines with a marketing authorisation valid in Northern Ireland (PL and PLNI) will require a unique identifier and a tamper evident device on each pack.</p>

<p>The unique identifiers on packs with a marketing authorisation valid in Northern Ireland (PL and PLNI) supplied by a manufacturer or wholesaler in the <abbr title="European Economic Area">EEA</abbr> will not require decommissioning when exported to the UK until the 31st December 2024. Unique identifiers on these packs should be decommissioned in Northern Ireland as required by <abbr title="European Union">EU</abbr> Delegated Regulation 2016/161.</p>

<p>Medicines with a marketing authorisation valid only in Great Britain (England, Wales and Scotland) labelled as PLGB will not require a Unique Identifier. However, we encourage companies to retain the tamper evidence device.  PLGB medicines must not be supplied to Northern Ireland unless specifically approved by <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>.</p>

<h2>Licensing requirements for medicines containing controlled drugs</h2>

<p>There will be no changes to licensing requirements for medicines containing controlled drugs. This is covered by UK legislation.</p>

<p>Controlled drugs are controlled in the UK under the Misuse of Drugs Act 1971 (‘the 1971 Act’) and the Misuse of Drugs Regulations 2001 (‘the 2001 Regulations’).</p>

<p>Home Office controlled drug import-export licensing requirements for trade in controlled drugs within the UK will not change.</p>

<p>Home Office controlled drug import-export licensing requirements for trade in controlled drugs from the UK, including from Northern Ireland, to the <abbr title="European Union">EU</abbr>, and vice versa, will not change.</p>

<p>See the <a class="govuk-link" href="https://www.gov.uk/government/publications/controlled-drugs-list--2/list-of-most-commonly-encountered-drugs-currently-controlled-under-the-misuse-of-drugs-legislation">list of the controlled drugs most enquired about</a>. The list is not exhaustive and, in the event of a substance not being listed, reference should also be made to the 1971 Act and the 2001 Regulations at legislation.gov.uk.</p>

<p>There are no new licensing requirements under the 1971 Act for companies moving medicines containing controlled drugs from Great Britain to Northern Ireland as a result of the Protocol.</p>

<p>See guidance on <a href="https://www.gov.uk/government/collections/drugs-licensing" class="govuk-link">how to apply for a Home Office controlled drug import-export licence</a> for trade in controlled drugs from the UK.</p>

<p>There are issues regarding ephedrine and pseudoephedrine containing medicinal products which fall within the definition of ‘Category 4’ Drug Precursor Chemicals. Trade between <abbr title="Great Britain">GB</abbr> and <abbr title="Northern Ireland">NI</abbr> will be subject to licensing in accordance with the requirements in Precursor chemical export and import authorisation. See Home Office guidance on <a href="https://www.gov.uk/guidance/precursor-chemical-licensing#gb-ni" class="govuk-link">precursor chemical licensing</a>.</p>

<h2>Contact</h2>

<p>For further information, please email our Customer Services Centre at info@mhra.gov.uk or call 020 3080 6000. Alternatively, contact your Trade Association by emailing:</p>

<ul>
  <li>Association of the British Pharmaceutical Industry (ABPI): <a href="mailto:regulatory@abpi.org.uk" class="govuk-link">regulatory@abpi.org.uk</a>
</li>
  <li>British Generic Manufacturers Association (BGMA): <a class="govuk-link" href="mailto:info@britishgenerics.co.uk">info@britishgenerics.co.uk</a>
</li>
  <li>BioIndustry Association (BIA): <a href="mailto:regulatory@bioindustry.org" class="govuk-link">regulatory@bioindustry.org</a>
</li>
  <li>Clinical &amp; Contract Research Association (CCRA): <a href="mailto:mail@ccra.org.uk" class="govuk-link">mail@ccra.org.uk</a>
</li>
  <li>Ethical Medicines Industry Group (EMIG): <a class="govuk-link" href="mailto:info@emig.org.uk">info@emig.org.uk</a>
</li>
  <li>Health Food Manufacturers’ Association (HFMA): <a class="govuk-link" href="mailto:pennyviner@btconnect.com">pennyviner@btconnect.com</a>
</li>
  <li>The National Pharmacy Association (NPA): <a class="govuk-link" href="mailto:independentsvoice@npa.co.uk">independentsvoice@npa.co.uk</a>
</li>
  <li>Proprietary Association of Great Britain (PAGB): <a class="govuk-link" href="mailto:regulatory@pagb.co.uk">regulatory@pagb.co.uk</a>
</li>
</ul>

</div>

</div>

      <div class="responsive-bottom-margin">
        <div class="app-c-published-dates app-c-published-dates--history govuk-!-margin-bottom-3" data-module="gem-toggle" lang="en">
    Published 31 December 2020
    <br>Last updated 22 December 2021
      <a data-expanded="false" data-controls="full-history" href="#full-history" class="app-c-published-dates__toggle govuk-link" data-toggled-text="-&nbsp;hide all updates">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-22T15:25:26.000+00:00">22 December 2021</time>
              <p class="app-c-published-dates__change-note">Update to post-Brexit protocols</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2020-12-31T23:01:00.000+00:00" class="app-c-published-dates__change-date timestamp">31 December 2020</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>


          
      </div>

      <div class="app-c-contents-list-with-body__link-wrapper" data-sticky-element="">
        <div class="app-c-contents-list-with-body__link-container">
          <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg viewBox="0 0 13 17" focusable="false" class="app-c-back-to-top__icon" xmlns="http://www.w3.org/2000/svg" width="13" height="17">
      <path fill="currentColor" d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z"></path>
    </svg>
    Contents
</a>

        </div>
      </div>
  </div>
    
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button data-module="print-link" class="govuk-link govuk-body-s gem-c-print-link__button">Print this page</button>
</div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>

  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav data-module="gem-toggle" role="navigation" class="gem-c-related-navigation__nav-section">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Manufacturing, wholesaling, importing and exporting medicines&quot;}" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines" href="/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer">Manufacturing, wholesaling, importing and exporting medicines</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Marketing authorisations, variations and licensing guidance&quot;}" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.2 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Medical devices regulation and safety&quot;}" data-track-category="relatedLinkClicked" data-track-action="1.3 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/medical-devices-regulation-safety" href="/topic/medicines-medical-devices-blood/medical-devices-regulation-safety" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer">Medical devices regulation and safety</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>